MedTrace Logo

Timolol Eye Drops in the Treatment of Acute Migraine Headache

NCT02630719 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-05-15

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine whether timolol eye drops are effective in alleviating acute migraine headaches. Subjects will be randomized to receive either timolol eye drops or placebo (tears) to use as a migraine abortive medication.

Conditions

Interventions

DRUG

Timolol eye drops

eye drops

DRUG

Artificial tears

Placebo drop

Sponsors & Collaborators

  • Truman Medical Center

    collaborator OTHER

  • University of Missouri, Kansas City

    lead OTHER

Principal Investigators

  • Sean Gratton, MD · UMKC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-08-01
Completion
2017-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02630719 on ClinicalTrials.gov